About NORVAXIS
Built on Conviction. Sustained by Results.
NORVAXIS Holdings is a privately held investment firm with over two decades of experience deploying capital across private equity, venture, real estate, and infrastructure. We are patient, disciplined, and deeply committed to the companies and partners we back.
Our History
Two Decades of Deliberate Growth
NORVAXIS was founded in 2006 by a small team of investment professionals who believed that the most durable returns come from long-duration thinking — not quarterly pressure. Starting with a focused mandate in private equity, the firm built its first portfolio of mid-market industrial and financial services companies across North America and Northern Europe.
By 2012, NORVAXIS had expanded into infrastructure and real estate, drawn by the same qualities that defined its early thesis: predictable cash flows, structural defensibility, and the ability to hold assets through cycles. The firm's infrastructure portfolio — anchored by long-concession assets in logistics and utilities — became one of its most consistent performers.
The launch of NORVAXIS Ventures in 2018 marked a deliberate expansion into early-stage technology and climate investing. Rather than chasing consensus, the Ventures arm was built to take concentrated positions in founders operating at the frontier of their fields — applying the same conviction-driven approach that had defined the firm since its founding.
Today, NORVAXIS manages $4.2 billion in assets across four investment verticals, with offices in New York, London, and Dubai. The firm remains privately held, with no external institutional investors — a structure that preserves the independence and long-term orientation that has defined every investment decision since 2006.
Founded in New York with a private equity mandate
First European office opened in London
Infrastructure and real estate verticals launched
Dubai office established; MENA expansion begins
NORVAXIS Ventures launched for early-stage investing
$4B AUM milestone reached
Investment Philosophy
Capital With Conviction
Long Duration
We measure our holding periods in years, not quarters. Our structure as a privately held firm means we are never forced to sell at the wrong time.
Concentrated Positions
We take meaningful stakes in a smaller number of companies rather than spreading capital thinly. Conviction requires concentration.
Operational Partnership
We do not sit on the sidelines. We work alongside management teams on strategy, talent, and capital structure — especially in the early years of an investment.
Cycle Resilience
Every investment is stress-tested against a downturn scenario. We look for businesses that can survive — and often thrive — when conditions deteriorate.
Leadership
The Partners
Alexander Voss
Founder & Managing Partner
Alexander founded NORVAXIS in 2006 after a decade at two leading private equity firms in New York and Frankfurt. He oversees the firm's overall investment strategy and chairs the Investment Committee. He holds an MBA from Wharton and a degree in economics from the University of St. Gallen.
Miriam Okafor
Partner, Private Equity
Miriam leads the firm's private equity vertical with a focus on healthcare, financial services, and consumer businesses. She joined NORVAXIS in 2009 from Goldman Sachs Principal Investments. She holds a JD from Columbia Law School and a BA from Yale University.
James Whitfield
Partner, Infrastructure & Real Estate
James oversees NORVAXIS's infrastructure and real estate portfolios across North America and Europe. Prior to joining in 2013, he spent eight years at Macquarie Capital structuring infrastructure transactions. He holds an MSc in Finance from London Business School.
Leila Nasseri
Partner, NORVAXIS Ventures
Leila leads NORVAXIS Ventures with a focus on AI infrastructure, climate technology, and defense-adjacent software. She was previously a General Partner at a San Francisco-based seed fund and an early engineer at two enterprise software companies. She holds a BS in Computer Science from MIT.
David Crane
Chief Financial Officer
David manages the firm's financial operations, fund administration, and investor reporting. He joined NORVAXIS in 2011 from Ernst & Young's transaction advisory practice. He is a CPA and holds a degree in accounting from the University of Michigan.
Sophia Lindqvist
General Counsel
Sophia oversees all legal, compliance, and regulatory matters across the firm's global operations. She joined in 2016 from Skadden Arps, where she advised on cross-border M&A and private fund formation. She holds a JD from NYU School of Law and an LLM from the University of Amsterdam.
What We Stand For
Principles That Don't Change
Integrity First
We do not pursue returns at the expense of our reputation. Every decision is made as if it will be scrutinized publicly.
Transparency With Partners
We communicate openly with our co-investors and portfolio companies — including when things are not going as planned.
Diversity of Perspective
Our team spans six nationalities and four continents. We believe diverse viewpoints produce better investment decisions.
Responsibility to Communities
The companies we back operate in real communities. We hold them — and ourselves — to high standards of environmental and social conduct.